EGFR and neoplasm: These antiglioma effects of Kae have been confirmed in vivo using xenograft tumor nude mice models, demonstrating that Kae effectively inhibits tumor growth and enhances the antitumor effects of Gef by targeting the EGFR/SRC/STAT3 signaling pathway [219].